HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$5.67
Day range
$5.66 - $6.00
Year range
$0.73 - $6.55
Market cap
383.01M USD
Avg Volume
316.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.62M | -59.04% |
Net income | -7.52M | 39.20% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.77M | -46.20% |
Total assets | 15.60M | -43.58% |
Total liabilities | 132.77M | 20.92% |
Total equity | -117.17M | — |
Shares outstanding | 64.06M | — |
Price to book | -3.05 | — |
Return on assets | -92.02% | — |
Return on capital | -2,208.69% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -7.52M | 39.20% |
Cash from operations | -6.60M | 20.77% |
Cash from investing | — | — |
Cash from financing | 12.94M | 24.73% |
Net change in cash | 6.34M | 210.33% |
Free cash flow | -5.97M | -21.88% |
About
Founded
2000
Headquarters
Website
Employees
15
